Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma.
Dhakal B, Veltri LW, Fenske TS, Eastwood D, Craig MD, Cumpston A, Shillingburg A, Esselman J, Watkins K, Pasquini MC, D'Souza A, Hari P, Kanate AS, Hamadani M. Dhakal B, et al. Among authors: kanate as. Biol Blood Marrow Transplant. 2016 Oct;22(10):1773-1780. doi: 10.1016/j.bbmt.2016.06.016. Epub 2016 Jun 21. Biol Blood Marrow Transplant. 2016. PMID: 27345140 Free article.
Bendamustine-associated hemolytic anemia.
Glance LE, Cumpston A, Kanate A, Remick SC. Glance LE, et al. Ann Pharmacother. 2009 Nov;43(11):1903-6. doi: 10.1345/aph.1M329. Epub 2009 Oct 6. Ann Pharmacother. 2009. PMID: 19809007
Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantation.
Kanate AS, Craig M, Cumpston A, Saad A, Hobbs G, Leadmon S, Bunner P, Watkins K, Bulian D, Gibson L, Abraham J, Remick SC, Hamadani M. Kanate AS, et al. Hematol Oncol Stem Cell Ther. 2011;4(4):149-56. doi: 10.5144/1658-3876.2011.149. Hematol Oncol Stem Cell Ther. 2011. PMID: 22198185 Free article.
Predictors and impact of thirty-day readmission on patient outcomes and health care costs after reduced-toxicity conditioning allogeneic hematopoietic cell transplantation.
Rauenzahn S, Truong Q, Cumpston A, Goff L, Leadmon S, Evans K, Zhang J, Wen S, Craig M, Hamadani M, Kanate AS. Rauenzahn S, et al. Among authors: kanate as. Biol Blood Marrow Transplant. 2014 Mar;20(3):415-20. doi: 10.1016/j.bbmt.2013.12.559. Epub 2013 Dec 18. Biol Blood Marrow Transplant. 2014. PMID: 24361913 Free PMC article.
Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.
Bachanova V, Burns LJ, Ahn KW, Laport GG, Akpek G, Kharfan-Dabaja MA, Nishihori T, Agura E, Armand P, Jaglowski SM, Cairo MS, Cashen AF, Cohen JB, D'Souza A, Freytes CO, Gale RP, Ganguly S, Ghosh N, Holmberg LA, Inwards DJ, Kanate AS, Lazarus HM, Malone AK, Munker R, Mussetti A, Norkin M, Prestidge TD, Rowe JM, Satwani P, Siddiqi T, Stiff PJ, William BM, Wirk B, Maloney DG, Smith SM, Sureda AM, Carreras J, Hamadani M; Center for International Blood and Marrow Transplant Research Lymphoma Working Committee. Bachanova V, et al. Among authors: kanate as. Biol Blood Marrow Transplant. 2015 Sep;21(9):1605-11. doi: 10.1016/j.bbmt.2015.05.007. Epub 2015 May 14. Biol Blood Marrow Transplant. 2015. PMID: 25983043 Free PMC article. Clinical Trial.
69 results